Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today
NCT ID: NCT06889727
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2023-08-09
2024-05-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto
NCT00327639
A Retrospective Study on the Effect of HBA or HBB Genetic Defects on Early Embryonic Development
NCT03687567
Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
NCT01496963
Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in France
NCT03119922
Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes
NCT02855957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnancy ended with the birth of a live or dead foetus
* Pregnancy ended in miscarriage or voluntary abortion
* Pregnancy in progress
Exclusion Criteria
* Pregnancy not initiated despite assisted fertilization practices
* Subjects unwilling to sign informed consent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UniversityCagliari, OspPed Microcitemico, Cagliari
Cagliari, CAGLIARI, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRAV001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.